Drug Pipeline

Quemliclustat Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
7
Active Studies
3
Recruiting
1
Phase 3
5
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 2
4
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06608927 Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With… Metastatic Pancreatic Ductal Adenocarcinoma Active, Not Recruiting
Phase 2
NCT06048133 Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced… Biliary Tract Carcinoma Recruiting
NCT06048484 Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma Pancreatic Ductal Adenocarcinoma Recruiting
NCT05676931 Study With Various Immunotherapy Treatments in Participants With Lung Cancer Advanced Non-Small Cell Lung Cancer Active, Not Recruiting
NCT05329766 A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in… Gastrointestinal Tract Malignancies Active, Not Recruiting
Phase 1/2
NCT05688215 Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of… Borderline Resectable Pancreatic Adenocarcinoma Recruiting
Phase 1
NCT04104672 A Study to Evaluate the Safety and Tolerability of AB680 in Participants With… Advanced Pancreatic Cancer Active, Not Recruiting
Sponsors Running Quemliclustat Trials
Arcus Biosciences, Inc. (3) Gilead Sciences (1) Jonsson Comprehensive Cancer Center (1) Nataliya Uboha (1) Gulam Manji (1)
Disease Areas
Pancreatic Cancer (4) Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1) Cholangiocarcinoma (1)
Get alerts when Quemliclustat trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free